Coya Therapeutics, Inc. (COYA)
(Real Time Quote from BATS)
$7.36 USD
+0.12 (1.66%)
Updated Jul 30, 2024 10:20 AM ET
3-Hold of 5 3
F Value D Growth B Momentum D VGM
Cash flow Statements
Fiscal Year End for Coya Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -7.99 | -12.24 | -4.89 | NA | NA |
Depreciation/Amortization & Depletion | 0.03 | 0.03 | 0.02 | NA | NA |
Net Change from Assets/Liabilities | -4.64 | 0.75 | 0.74 | NA | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | NA | NA |
Other Operating Activities | 1.42 | 4.23 | 0.23 | NA | NA |
Net Cash From Operating Activities | -11.19 | -7.24 | -3.90 | NA | NA |
Property & Equipment | -0.54 | -0.53 | -0.14 | NA | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | NA | NA |
Investments | 0.00 | 0.00 | 0.00 | NA | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | NA | NA |
Net Cash from Investing Activities | -0.54 | -0.53 | -0.14 | NA | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 38.43 | 0.00 | 0.00 | NA | NA |
Issuance (Repayment) of Debt | 0.00 | 10.36 | 0.00 | NA | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | NA | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | NA | NA |
Other Financing Activities | 0.00 | -1.00 | -0.34 | NA | NA |
Net Cash from Financing Activities | 38.43 | 9.36 | -0.34 | NA | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | NA | NA |
Net Change In Cash & Equivalents | 26.69 | 1.59 | -4.38 | NA | NA |
Cash at Beginning of Period | 5.93 | 4.34 | 8.72 | NA | NA |
Cash at End of Period | 32.63 | 5.93 | 4.34 | NA | NA |
Diluted Net EPS | -0.79 | -4.73 | -1.89 | NA | NA |
Fiscal Year End for Coya Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -5.05 | -7.99 | -9.25 | -5.83 |
Depreciation/Amortization & Depletion | NA | 0.01 | 0.03 | 0.02 | 0.01 |
Net Change from Assets/Liabilities | NA | 6.73 | -4.64 | -0.70 | -1.63 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 0.46 | 1.42 | 0.98 | 0.72 |
Net Cash From Operating Activities | NA | 2.15 | -11.19 | -8.95 | -6.73 |
Property & Equipment | NA | -0.03 | -0.54 | -0.35 | -0.35 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -0.03 | -0.54 | -0.35 | -0.35 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 1.36 | 38.43 | 0.00 | 14.25 |
Issuance (Repayment) of Debt | NA | -0.13 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.01 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 1.24 | 38.43 | 14.25 | 14.25 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 3.36 | 26.69 | 4.95 | 7.17 |
Cash at Beginning of Period | NA | 32.63 | 5.93 | 5.93 | 5.93 |
Cash at End of Period | NA | 35.99 | 32.63 | 10.89 | 13.10 |
Diluted Net EPS | NA | -0.35 | 0.14 | -0.34 | -0.31 |